Follow The Filings

VNDA position history

The shares of Vanda Pharmaceuticals (VNDA) that HORIZON KINETICS ASSET MANAGEMENT LLC reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2023 Q1: 27,000 shares, $183K, <0.01% of portfolio, New
  2. 2023 Q2: 27,000 shares, $178K, <0.01% of portfolio
  3. 2023 Q3: 27,000 shares, $117K, <0.01% of portfolio
  4. 2023 Q4: 25,912 shares, $109K, <0.01% of portfolio, Reduce −4.0%
  5. 2024 Q1: 25,912 shares, $106K, <0.01% of portfolio
  6. 2024 Q2: 25,912 shares, $146K, <0.01% of portfolio
  7. 2024 Q3: 24,824 shares, $116K, <0.01% of portfolio, Reduce −4.2%
  8. 2024 Q4: 25,912 shares, $124K, <0.01% of portfolio, Add +4.4%
  9. 2025 Q1: 25,912 shares, $119K, <0.01% of portfolio
  10. 2025 Q2: 24,824 shares, $117K, <0.01% of portfolio, Reduce −4.2%
  11. 2025 Q3: 25,912 shares, $129K, <0.01% of portfolio, Add +4.4%
  12. 2025 Q4: 24,824 shares, $219K, <0.01% of portfolio, Reduce −4.2%
  13. 2026 Q1: 23,736 shares, $164K, <0.01% of portfolio, Reduce −4.4%
  14. 2026 Q2: 22,648 shares, $139K, <0.01% of portfolio, Reduce −4.6%
Holdings date Value % of holdings Shares Filing date All 13F holders